DBV Technologies S.A.
DBV Technologies develops epicutaneous immunotherapy patches for food allergies.
8-KSep 30Latest SEC filing, period to Sep 29
Sep 29Latest story
September 2026
July 2026
Sign inSign inDBV Technologies develops epicutaneous immunotherapy patches for food allergies.